Samsung Becomes Largest Shareholder in US Genomics Firm Element Biosciences
Samsung Electronics has invested $175 million in Element Biosciences' Series E funding round, making it the largest shareholder in the US genomics firm. This strategic investment positions Samsung as a key player in the biotech sector.